WS #5761

The data dump contains several high-signal items. Warner Bros. Discovery shareholders approved the $110B merger with Paramount Skydance, creating a media giant. This is a major M&A development with cross-source corroboration (GDELT, Seeking Alpha). Regeneron received FDA approval for Otarmeni, the first gene therapy for genetic hearing loss, and will provide it for free in the US, a significant biotech catalyst. Microsoft is offering voluntary buyouts to up to 7% of US employees, signaling cost-cutting. Skillz shares surged over 82% after winning a $420M judgment, triggering multiple trading halts. On the geopolitical front, Iran claims enriched uranium cannot be safely transported, challenging Trump's narrative, while US oil CEOs met Venezuela's president to discuss oil revival, potentially impacting supply. The DOJ plans to revoke citizenship of hundreds, a political development. Tesla shares fell 3.4% despite a Q1 beat, as investors focused on negative free cash flow guidance for 2026. Lockheed Martin's CEO called the Trump Pentagon a 'golden opportunity' for growth. The Warner-Paramount merger is the most significant corporate event, with broad media sector implications.